Clinical Trial Update: Allogeneic Platelet Rich Plasma (PRP) to Treat Diabetic Foot Ulcers [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial evaluating allogeneic platelet-rich plasma (PRP) for diabetic foot ulcers has completed Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer

Drugs mentioned

• Allogeneic Platelet Rich Plasma (PRP) (platelet-rich plasma)

Snippet

Sponsor: Ospedale Policlinico San Martino | Conditions: Diabetic Foot Ulcer, Skin Lesions | Phase 1, Phase 2 | Status: COMPLETED